- Home
- IINN vs HOWL Comparison
IINN vs HOWL Comparison
Compare IINN & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IINN | HOWL |
|---|---|---|
| Founded | 2018 | 2017 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.3M | 30.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | IINN | HOWL |
|---|---|---|
| Price | $0.56 | $0.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $2.00 | ★ $7.00 |
| AVG Volume (30 Days) | 144.0K | ★ 386.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9,715.95 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.40 | $0.53 |
| 52 Week High | $1.65 | $2.23 |
Technical Indicators
Market Signals| Indicator | IINN | HOWL |
|---|---|---|
| Relative Strength Index (RSI) | 31.12 | 59.39 |
| Support Level | $0.55 | $0.56 |
| Resistance Level | $0.64 | $0.80 |
| Average True Range (ATR) | 0.03 | 0.07 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 6.00 | 66.74 |
Price Performance
Historical ComparisonAbout IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.